Comparison of epigenetic versus standard induction chemotherapy for newly diagnosed acute myeloid leukemia patients ≥60 years old-Reference-Cited by-同舟云学术

Comparison of epigenetic versus standard induction chemotherapy for newly diagnosed acute myeloid leukemia patients ≥60 years old

Published:2015-06-22 Issue:7 Volume:90 Page:639-646
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Gupta Neha¹,Miller Austin²,Gandhi Shipra¹,Ford Laurie A.³,Vigil Carlos E.³,Griffiths Elizabeth A.³,Thompson James E.³,Wetzler Meir³,Wang Eunice S.³

Affiliation:

1. Department of Medicine; SUNY-UB School of Medicine; Buffalo New York

2. Department of Biostatistics; Roswell Park Cancer Institute; Buffalo New York

3. Leukemia Service, Department of Medicine; Roswell Park Cancer Institute; Buffalo New York

Funder

National Cancer Institute

Publisher

Wiley

Subject

Hematology

Reference54 articles.

1. High activity and incomplete cross resistance of nucleoside analogues cladribine and fludarabine versus Ara-C on leukemic cells from patients with AML;Lofgren;Ther Drug Monit,2005

2. Acute myeloid leukaemia;Estey;Lancet,2006

3. Acute myeloid leukemia in the elderly: ‘Per aspera ad astra’?;Latagliata;Leuk Res,1999

4. Treatment of older adults with acute myeloid leukemia: State of the art and current perspectives;Sekeres;Haematologica,2008

5. Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: A Southwest Oncology Group Study;Leith;Blood,1999

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Follow-Up of Elderly Patients with Acute Myeloid Leukemia Treated with Decitabine: A Real-World Study of the Apulian Hematological Network;Cancers;2022-02-06

2. Blood Count Recovery Following Induction Therapy for Acute Myeloid Leukemia in Children Does Not Predict Survival;Cancers;2022-01-26

3. Dose intensity for induction in acute myeloid leukemia: what, when, and for whom?;Haematologica;2021-07-29

4. Hypomethylating Chemotherapeutic Agents as Therapy for Myelodysplastic Syndromes and Prevention of Acute Myeloid Leukemia;Pharmaceuticals;2021-07-04

5. Efficacy of 10-day decitabine in acute myeloid leukemia;Leukemia Research;2021-04